Gen Digital Inc. (GEN) Stock Competitors & Peer Comparison
See (GEN) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Infrastructure Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GEN | $26.61 | +0.42% | 16B | 16.89 | $1.57 | +1.86% |
| MSFT | $417.20 | -2.37% | 3.2T | 25.46 | $16.81 | +0.83% |
| ORCL | $210.14 | -8.77% | 679.8B | 42.51 | $5.56 | +0.84% |
| PLTR | $134.89 | -5.14% | 325.4B | 161.03 | $0.88 | N/A |
| PANW | $272.45 | -2.85% | 190.3B | 242.83 | $1.15 | N/A |
| CRWD | $678.78 | -9.21% | 183B | -10272.71 | -$0.07 | N/A |
| FTNT | $144.13 | -1.61% | 109.7B | 58.01 | $2.58 | N/A |
| NET | $247.65 | -6.66% | 95B | -1074.56 | -$0.25 | N/A |
| SNPS | $463.22 | -6.99% | 94.7B | 112.89 | $4.38 | N/A |
| VMW | $142.48 | -4.96% | 61.5B | 42.92 | $3.32 | N/A |
Stock Comparison
GEN vs MSFT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, MSFT has a market cap of 3.2T. Regarding current trading prices, GEN is priced at $26.61, while MSFT trades at $417.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas MSFT's P/E ratio is 25.46. In terms of profitability, GEN's ROE is +0.40%, compared to MSFT's ROE of +0.33%. Regarding short-term risk, GEN is less volatile compared to MSFT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check MSFT's competition here
GEN vs ORCL Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, ORCL has a market cap of 679.8B. Regarding current trading prices, GEN is priced at $26.61, while ORCL trades at $210.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas ORCL's P/E ratio is 42.51. In terms of profitability, GEN's ROE is +0.40%, compared to ORCL's ROE of +0.57%. Regarding short-term risk, GEN is less volatile compared to ORCL. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ORCL's competition here
GEN vs PLTR Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, PLTR has a market cap of 325.4B. Regarding current trading prices, GEN is priced at $26.61, while PLTR trades at $134.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas PLTR's P/E ratio is 161.03. In terms of profitability, GEN's ROE is +0.40%, compared to PLTR's ROE of +0.32%. Regarding short-term risk, GEN is less volatile compared to PLTR. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PLTR's competition here
GEN vs PANW Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, PANW has a market cap of 190.3B. Regarding current trading prices, GEN is priced at $26.61, while PANW trades at $272.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas PANW's P/E ratio is 242.83. In terms of profitability, GEN's ROE is +0.40%, compared to PANW's ROE of +0.06%. Regarding short-term risk, GEN is less volatile compared to PANW. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PANW's competition here
GEN vs CRWD Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CRWD has a market cap of 183B. Regarding current trading prices, GEN is priced at $26.61, while CRWD trades at $678.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CRWD's P/E ratio is -10272.71. In terms of profitability, GEN's ROE is +0.40%, compared to CRWD's ROE of -0.00%. Regarding short-term risk, GEN is less volatile compared to CRWD. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CRWD's competition here
GEN vs FTNT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, FTNT has a market cap of 109.7B. Regarding current trading prices, GEN is priced at $26.61, while FTNT trades at $144.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas FTNT's P/E ratio is 58.01. In terms of profitability, GEN's ROE is +0.40%, compared to FTNT's ROE of +1.56%. Regarding short-term risk, GEN is less volatile compared to FTNT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check FTNT's competition here
GEN vs NET Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, NET has a market cap of 95B. Regarding current trading prices, GEN is priced at $26.61, while NET trades at $247.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas NET's P/E ratio is -1074.56. In terms of profitability, GEN's ROE is +0.40%, compared to NET's ROE of -0.06%. Regarding short-term risk, GEN is less volatile compared to NET. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NET's competition here
GEN vs SNPS Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, SNPS has a market cap of 94.7B. Regarding current trading prices, GEN is priced at $26.61, while SNPS trades at $463.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas SNPS's P/E ratio is 112.89. In terms of profitability, GEN's ROE is +0.40%, compared to SNPS's ROE of +0.03%. Regarding short-term risk, GEN is less volatile compared to SNPS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check SNPS's competition here
GEN vs VMW Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, GEN is priced at $26.61, while VMW trades at $142.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas VMW's P/E ratio is 42.92. In terms of profitability, GEN's ROE is +0.40%, compared to VMW's ROE of +3.99%. Regarding short-term risk, GEN is more volatile compared to VMW. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check VMW's competition here
GEN vs CRWV Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CRWV has a market cap of 58.9B. Regarding current trading prices, GEN is priced at $26.61, while CRWV trades at $95.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CRWV's P/E ratio is -39.72. In terms of profitability, GEN's ROE is +0.40%, compared to CRWV's ROE of -0.40%. Regarding short-term risk, GEN is less volatile compared to CRWV. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CRWV's competition here
GEN vs SQ Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, GEN is priced at $26.61, while SQ trades at $83.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas SQ's P/E ratio is 49.98. In terms of profitability, GEN's ROE is +0.40%, compared to SQ's ROE of -0.02%. Regarding short-term risk, GEN is less volatile compared to SQ. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check SQ's competition here
GEN vs XYZ Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, XYZ has a market cap of 42.2B. Regarding current trading prices, GEN is priced at $26.61, while XYZ trades at $67.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas XYZ's P/E ratio is 55.37. In terms of profitability, GEN's ROE is +0.40%, compared to XYZ's ROE of +0.04%. Regarding short-term risk, GEN is less volatile compared to XYZ. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check XYZ's competition here
GEN vs TWLO Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, TWLO has a market cap of 35.9B. Regarding current trading prices, GEN is priced at $26.61, while TWLO trades at $229.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas TWLO's P/E ratio is 358.61. In terms of profitability, GEN's ROE is +0.40%, compared to TWLO's ROE of +0.01%. Regarding short-term risk, GEN is less volatile compared to TWLO. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check TWLO's competition here
GEN vs MDB Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, MDB has a market cap of 30.6B. Regarding current trading prices, GEN is priced at $26.61, while MDB trades at $351.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas MDB's P/E ratio is -1056.06. In terms of profitability, GEN's ROE is +0.40%, compared to MDB's ROE of -0.01%. Regarding short-term risk, GEN is less volatile compared to MDB. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check MDB's competition here
GEN vs NETE Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, GEN is priced at $26.61, while NETE trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas NETE's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to NETE's ROE of +3.34%. Regarding short-term risk, GEN is less volatile compared to NETE. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NETE's competition here
GEN vs VRSN Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, VRSN has a market cap of 26.7B. Regarding current trading prices, GEN is priced at $26.61, while VRSN trades at $295.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas VRSN's P/E ratio is 32.50. In terms of profitability, GEN's ROE is +0.40%, compared to VRSN's ROE of -0.40%. Regarding short-term risk, GEN is more volatile compared to VRSN. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check VRSN's competition here
GEN vs SPLK Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, GEN is priced at $26.61, while SPLK trades at $156.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas SPLK's P/E ratio is 103.22. In terms of profitability, GEN's ROE is +0.40%, compared to SPLK's ROE of +0.84%. Regarding short-term risk, GEN is more volatile compared to SPLK. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SPLK's competition here
GEN vs CPAY Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CPAY has a market cap of 23.3B. Regarding current trading prices, GEN is priced at $26.61, while CPAY trades at $350.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CPAY's P/E ratio is 21.38. In terms of profitability, GEN's ROE is +0.40%, compared to CPAY's ROE of +0.31%. Regarding short-term risk, GEN is less volatile compared to CPAY. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CPAY's competition here
GEN vs AKAM Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, AKAM has a market cap of 23.1B. Regarding current trading prices, GEN is priced at $26.61, while AKAM trades at $148.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas AKAM's P/E ratio is 53.53. In terms of profitability, GEN's ROE is +0.40%, compared to AKAM's ROE of +0.09%. Regarding short-term risk, GEN is less volatile compared to AKAM. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check AKAM's competition here
GEN vs FFIV Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, FFIV has a market cap of 23.1B. Regarding current trading prices, GEN is priced at $26.61, while FFIV trades at $395.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas FFIV's P/E ratio is 33.58. In terms of profitability, GEN's ROE is +0.40%, compared to FFIV's ROE of +0.20%. Regarding short-term risk, GEN is less volatile compared to FFIV. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check FFIV's competition here
GEN vs AFRM Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, AFRM has a market cap of 23B. Regarding current trading prices, GEN is priced at $26.61, while AFRM trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas AFRM's P/E ratio is 62.45. In terms of profitability, GEN's ROE is +0.40%, compared to AFRM's ROE of +0.11%. Regarding short-term risk, GEN is less volatile compared to AFRM. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check AFRM's competition here
GEN vs ZS Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, ZS has a market cap of 21.9B. Regarding current trading prices, GEN is priced at $26.61, while ZS trades at $129.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas ZS's P/E ratio is -281.79. In terms of profitability, GEN's ROE is +0.40%, compared to ZS's ROE of -0.04%. Regarding short-term risk, GEN is less volatile compared to ZS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ZS's competition here
GEN vs FLT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, GEN is priced at $26.61, while FLT trades at $303.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas FLT's P/E ratio is 22.97. In terms of profitability, GEN's ROE is +0.40%, compared to FLT's ROE of +0.31%. Regarding short-term risk, GEN is more volatile compared to FLT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check FLT's competition here
GEN vs OKTA Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, OKTA has a market cap of 20.7B. Regarding current trading prices, GEN is priced at $26.61, while OKTA trades at $118.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas OKTA's P/E ratio is 89.46. In terms of profitability, GEN's ROE is +0.40%, compared to OKTA's ROE of +0.04%. Regarding short-term risk, GEN is less volatile compared to OKTA. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check OKTA's competition here
GEN vs CYBR Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CYBR has a market cap of 20.6B. Regarding current trading prices, GEN is priced at $26.61, while CYBR trades at $408.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CYBR's P/E ratio is -139.06. In terms of profitability, GEN's ROE is +0.40%, compared to CYBR's ROE of -0.06%. Regarding short-term risk, GEN is more volatile compared to CYBR. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CYBR's competition here
GEN vs IOT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, IOT has a market cap of 20.2B. Regarding current trading prices, GEN is priced at $26.61, while IOT trades at $34.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas IOT's P/E ratio is -1761.50. In terms of profitability, GEN's ROE is +0.40%, compared to IOT's ROE of -0.01%. Regarding short-term risk, GEN is less volatile compared to IOT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check IOT's competition here
GEN vs DOCN Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, DOCN has a market cap of 18.8B. Regarding current trading prices, GEN is priced at $26.61, while DOCN trades at $163.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas DOCN's P/E ratio is 79.20. In terms of profitability, GEN's ROE is +0.40%, compared to DOCN's ROE of +1.54%. Regarding short-term risk, GEN is less volatile compared to DOCN. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check DOCN's competition here
GEN vs KSPI Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, KSPI has a market cap of 15.8B. Regarding current trading prices, GEN is priced at $26.61, while KSPI trades at $81.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas KSPI's P/E ratio is 7.26. In terms of profitability, GEN's ROE is +0.40%, compared to KSPI's ROE of +0.44%. Regarding short-term risk, GEN is less volatile compared to KSPI. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check KSPI's competition here
GEN vs RBRK Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, RBRK has a market cap of 15.6B. Regarding current trading prices, GEN is priced at $26.61, while RBRK trades at $72.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas RBRK's P/E ratio is -43.24. In terms of profitability, GEN's ROE is +0.40%, compared to RBRK's ROE of +0.64%. Regarding short-term risk, GEN is less volatile compared to RBRK. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check RBRK's competition here
GEN vs NTNX Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, NTNX has a market cap of 14.9B. Regarding current trading prices, GEN is priced at $26.61, while NTNX trades at $53.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas NTNX's P/E ratio is 57.86. In terms of profitability, GEN's ROE is +0.40%, compared to NTNX's ROE of -0.38%. Regarding short-term risk, GEN is less volatile compared to NTNX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NTNX's competition here
GEN vs TOST Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, TOST has a market cap of 14.6B. Regarding current trading prices, GEN is priced at $26.61, while TOST trades at $24.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas TOST's P/E ratio is 37.64. In terms of profitability, GEN's ROE is +0.40%, compared to TOST's ROE of +0.21%. Regarding short-term risk, GEN is less volatile compared to TOST. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check TOST's competition here
GEN vs NLOK Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, GEN is priced at $26.61, while NLOK trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas NLOK's P/E ratio is 15.15. In terms of profitability, GEN's ROE is +0.40%, compared to NLOK's ROE of +0.40%. Regarding short-term risk, GEN is less volatile compared to NLOK. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NLOK's competition here
GEN vs CHKP Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CHKP has a market cap of 14.2B. Regarding current trading prices, GEN is priced at $26.61, while CHKP trades at $136.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CHKP's P/E ratio is 14.04. In terms of profitability, GEN's ROE is +0.40%, compared to CHKP's ROE of +0.36%. Regarding short-term risk, GEN is more volatile compared to CHKP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CHKP's competition here
GEN vs GDDY Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, GDDY has a market cap of 11.2B. Regarding current trading prices, GEN is priced at $26.61, while GDDY trades at $84.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas GDDY's P/E ratio is 13.45. In terms of profitability, GEN's ROE is +0.40%, compared to GDDY's ROE of +3.67%. Regarding short-term risk, GEN is less volatile compared to GDDY. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check GDDY's competition here
GEN vs CFLT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CFLT has a market cap of 11.1B. Regarding current trading prices, GEN is priced at $26.61, while CFLT trades at $30.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CFLT's P/E ratio is -36.03. In terms of profitability, GEN's ROE is +0.40%, compared to CFLT's ROE of -0.27%. Regarding short-term risk, GEN is more volatile compared to CFLT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CFLT's competition here
GEN vs PAYP Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, PAYP has a market cap of 10.7B. Regarding current trading prices, GEN is priced at $26.61, while PAYP trades at $15.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas PAYP's P/E ratio is 14.05. In terms of profitability, GEN's ROE is +0.40%, compared to PAYP's ROE of +0.58%. Regarding short-term risk, GEN is less volatile compared to PAYP. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PAYP's competition here
GEN vs SAIL Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, SAIL has a market cap of 10.6B. Regarding current trading prices, GEN is priced at $26.61, while SAIL trades at $18.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas SAIL's P/E ratio is -34.46. In terms of profitability, GEN's ROE is +0.40%, compared to SAIL's ROE of -0.04%. Regarding short-term risk, GEN is less volatile compared to SAIL. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check SAIL's competition here
GEN vs ALTR Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, GEN is priced at $26.61, while ALTR trades at $111.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas ALTR's P/E ratio is 699.06. In terms of profitability, GEN's ROE is +0.40%, compared to ALTR's ROE of +0.02%. Regarding short-term risk, GEN is more volatile compared to ALTR. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check ALTR's competition here
GEN vs PLAN Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, GEN is priced at $26.61, while PLAN trades at $63.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas PLAN's P/E ratio is -44.82. In terms of profitability, GEN's ROE is +0.40%, compared to PLAN's ROE of -0.78%. Regarding short-term risk, GEN is more volatile compared to PLAN. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check PLAN's competition here
GEN vs CORZ Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CORZ has a market cap of 8.9B. Regarding current trading prices, GEN is priced at $26.61, while CORZ trades at $25.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CORZ's P/E ratio is -8.31. In terms of profitability, GEN's ROE is +0.40%, compared to CORZ's ROE of +1.09%. Regarding short-term risk, GEN is less volatile compared to CORZ. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CORZ's competition here
GEN vs CORZZ Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CORZZ has a market cap of 8.9B. Regarding current trading prices, GEN is priced at $26.61, while CORZZ trades at $25.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CORZZ's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to CORZZ's ROE of +1.09%. Regarding short-term risk, GEN is less volatile compared to CORZZ. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CORZZ's competition here
GEN vs INFA Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, INFA has a market cap of 7.5B. Regarding current trading prices, GEN is priced at $26.61, while INFA trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas INFA's P/E ratio is 826.33. In terms of profitability, GEN's ROE is +0.40%, compared to INFA's ROE of +0.00%. Regarding short-term risk, GEN is more volatile compared to INFA. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check INFA's competition here
GEN vs HCP Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, HCP has a market cap of 7.1B. Regarding current trading prices, GEN is priced at $26.61, while HCP trades at $34.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas HCP's P/E ratio is -57.97. In terms of profitability, GEN's ROE is +0.40%, compared to HCP's ROE of -0.16%. Regarding short-term risk, GEN is more volatile compared to HCP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check HCP's competition here
GEN vs DBX Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, DBX has a market cap of 6.9B. Regarding current trading prices, GEN is priced at $26.61, while DBX trades at $27.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas DBX's P/E ratio is 14.86. In terms of profitability, GEN's ROE is +0.40%, compared to DBX's ROE of -0.28%. Regarding short-term risk, GEN is less volatile compared to DBX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check DBX's competition here
GEN vs JCOM Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, GEN is priced at $26.61, while JCOM trades at $142.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas JCOM's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to JCOM's ROE of +0.06%. Regarding short-term risk, GEN is less volatile compared to JCOM. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check JCOM's competition here
GEN vs CORZW Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CORZW has a market cap of 6.7B. Regarding current trading prices, GEN is priced at $26.61, while CORZW trades at $18.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CORZW's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to CORZW's ROE of +1.09%. Regarding short-term risk, GEN is less volatile compared to CORZW. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CORZW's competition here
GEN vs KLAR Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, KLAR has a market cap of 6.6B. Regarding current trading prices, GEN is priced at $26.61, while KLAR trades at $16.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas KLAR's P/E ratio is -33.59. In terms of profitability, GEN's ROE is +0.40%, compared to KLAR's ROE of -0.08%. Regarding short-term risk, GEN is less volatile compared to KLAR. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check KLAR's competition here
GEN vs DOX Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, DOX has a market cap of 6.5B. Regarding current trading prices, GEN is priced at $26.61, while DOX trades at $60.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas DOX's P/E ratio is 12.14. In terms of profitability, GEN's ROE is +0.40%, compared to DOX's ROE of +0.16%. Regarding short-term risk, GEN is less volatile compared to DOX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check DOX's competition here
GEN vs SQSP Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, GEN is priced at $26.61, while SQSP trades at $46.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, GEN's ROE is +0.40%, compared to SQSP's ROE of +0.03%. Regarding short-term risk, GEN is more volatile compared to SQSP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SQSP's competition here
GEN vs PATH Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, PATH has a market cap of 6.2B. Regarding current trading prices, GEN is priced at $26.61, while PATH trades at $11.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas PATH's P/E ratio is 19.47. In terms of profitability, GEN's ROE is +0.40%, compared to PATH's ROE of +0.17%. Regarding short-term risk, GEN is less volatile compared to PATH. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PATH's competition here
GEN vs NEWR Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, GEN is priced at $26.61, while NEWR trades at $86.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas NEWR's P/E ratio is -41.62. In terms of profitability, GEN's ROE is +0.40%, compared to NEWR's ROE of -0.54%. Regarding short-term risk, GEN is more volatile compared to NEWR. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check NEWR's competition here
GEN vs BB Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, BB has a market cap of 6.1B. Regarding current trading prices, GEN is priced at $26.61, while BB trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas BB's P/E ratio is 114.72. In terms of profitability, GEN's ROE is +0.40%, compared to BB's ROE of +0.07%. Regarding short-term risk, GEN is less volatile compared to BB. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check BB's competition here
GEN vs CCCS Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CCCS has a market cap of 5.6B. Regarding current trading prices, GEN is priced at $26.61, while CCCS trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CCCS's P/E ratio is -875.00. In terms of profitability, GEN's ROE is +0.40%, compared to CCCS's ROE of +0.02%. Regarding short-term risk, GEN is less volatile compared to CCCS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CCCS's competition here
GEN vs S Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, S has a market cap of 5.6B. Regarding current trading prices, GEN is priced at $26.61, while S trades at $15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas S's P/E ratio is -17.06. In terms of profitability, GEN's ROE is +0.40%, compared to S's ROE of -0.21%. Regarding short-term risk, GEN is less volatile compared to S. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check S's competition here
GEN vs WEX Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, WEX has a market cap of 5.1B. Regarding current trading prices, GEN is priced at $26.61, while WEX trades at $148.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas WEX's P/E ratio is 16.54. In terms of profitability, GEN's ROE is +0.40%, compared to WEX's ROE of +0.27%. Regarding short-term risk, GEN is more volatile compared to WEX. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check WEX's competition here
GEN vs NVEI Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, GEN is priced at $26.61, while NVEI trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas NVEI's P/E ratio is 212.44. In terms of profitability, GEN's ROE is +0.40%, compared to NVEI's ROE of -0.00%. Regarding short-term risk, GEN is more volatile compared to NVEI. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check NVEI's competition here
GEN vs KVYO Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, KVYO has a market cap of 4.7B. Regarding current trading prices, GEN is priced at $26.61, while KVYO trades at $15.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas KVYO's P/E ratio is -526.17. In terms of profitability, GEN's ROE is +0.40%, compared to KVYO's ROE of -0.01%. Regarding short-term risk, GEN is less volatile compared to KVYO. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check KVYO's competition here
GEN vs BLSH Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, BLSH has a market cap of 4.5B. Regarding current trading prices, GEN is priced at $26.61, while BLSH trades at $27.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas BLSH's P/E ratio is -3.96. In terms of profitability, GEN's ROE is +0.40%, compared to BLSH's ROE of -0.33%. Regarding short-term risk, GEN is less volatile compared to BLSH. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check BLSH's competition here
GEN vs ACIW Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, ACIW has a market cap of 4.3B. Regarding current trading prices, GEN is priced at $26.61, while ACIW trades at $43.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas ACIW's P/E ratio is 21.39. In terms of profitability, GEN's ROE is +0.40%, compared to ACIW's ROE of +0.14%. Regarding short-term risk, GEN is less volatile compared to ACIW. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ACIW's competition here
GEN vs RELY Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, RELY has a market cap of 4.2B. Regarding current trading prices, GEN is priced at $26.61, while RELY trades at $18.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas RELY's P/E ratio is 41.27. In terms of profitability, GEN's ROE is +0.40%, compared to RELY's ROE of +0.13%. Regarding short-term risk, GEN is less volatile compared to RELY. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check RELY's competition here
GEN vs QLYS Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, QLYS has a market cap of 3.9B. Regarding current trading prices, GEN is priced at $26.61, while QLYS trades at $109.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas QLYS's P/E ratio is 20.02. In terms of profitability, GEN's ROE is +0.40%, compared to QLYS's ROE of +0.37%. Regarding short-term risk, GEN is less volatile compared to QLYS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check QLYS's competition here
GEN vs VRNS Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, VRNS has a market cap of 3.9B. Regarding current trading prices, GEN is priced at $26.61, while VRNS trades at $32.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas VRNS's P/E ratio is -29.42. In terms of profitability, GEN's ROE is +0.40%, compared to VRNS's ROE of -0.26%. Regarding short-term risk, GEN is less volatile compared to VRNS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check VRNS's competition here
GEN vs ESMT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, GEN is priced at $26.61, while ESMT trades at $23.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas ESMT's P/E ratio is 153.67. In terms of profitability, GEN's ROE is +0.40%, compared to ESMT's ROE of +0.03%. Regarding short-term risk, GEN is more volatile compared to ESMT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check ESMT's competition here
GEN vs FOUR Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, FOUR has a market cap of 3.6B. Regarding current trading prices, GEN is priced at $26.61, while FOUR trades at $38.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas FOUR's P/E ratio is 45.16. In terms of profitability, GEN's ROE is +0.40%, compared to FOUR's ROE of +0.06%. Regarding short-term risk, GEN is less volatile compared to FOUR. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check FOUR's competition here
GEN vs CLBT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CLBT has a market cap of 3.6B. Regarding current trading prices, GEN is priced at $26.61, while CLBT trades at $13.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CLBT's P/E ratio is 51.04. In terms of profitability, GEN's ROE is +0.40%, compared to CLBT's ROE of +0.16%. Regarding short-term risk, GEN is less volatile compared to CLBT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CLBT's competition here
GEN vs DLO Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, DLO has a market cap of 3.5B. Regarding current trading prices, GEN is priced at $26.61, while DLO trades at $11.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas DLO's P/E ratio is 18.39. In terms of profitability, GEN's ROE is +0.40%, compared to DLO's ROE of +0.37%. Regarding short-term risk, GEN is less volatile compared to DLO. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check DLO's competition here
GEN vs TDC Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, TDC has a market cap of 3.3B. Regarding current trading prices, GEN is priced at $26.61, while TDC trades at $33.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas TDC's P/E ratio is 7.98. In terms of profitability, GEN's ROE is +0.40%, compared to TDC's ROE of +1.42%. Regarding short-term risk, GEN is less volatile compared to TDC. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check TDC's competition here
GEN vs TENB Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, TENB has a market cap of 3.2B. Regarding current trading prices, GEN is priced at $26.61, while TENB trades at $27.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas TENB's P/E ratio is -292.90. In terms of profitability, GEN's ROE is +0.40%, compared to TENB's ROE of -0.04%. Regarding short-term risk, GEN is less volatile compared to TENB. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check TENB's competition here
GEN vs SWI Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, GEN is priced at $26.61, while SWI trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas SWI's P/E ratio is 28.89. In terms of profitability, GEN's ROE is +0.40%, compared to SWI's ROE of +0.08%. Regarding short-term risk, GEN is more volatile compared to SWI. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SWI's competition here
GEN vs NTCT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, NTCT has a market cap of 3B. Regarding current trading prices, GEN is priced at $26.61, while NTCT trades at $40.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas NTCT's P/E ratio is 32.47. In terms of profitability, GEN's ROE is +0.40%, compared to NTCT's ROE of +0.06%. Regarding short-term risk, GEN is less volatile compared to NTCT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NTCT's competition here
GEN vs EVOP Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, GEN is priced at $26.61, while EVOP trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas EVOP's P/E ratio is -309.00. In terms of profitability, GEN's ROE is +0.40%, compared to EVOP's ROE of -0.03%. Regarding short-term risk, GEN is more volatile compared to EVOP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check EVOP's competition here
GEN vs WIX Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, WIX has a market cap of 3B. Regarding current trading prices, GEN is priced at $26.61, while WIX trades at $52.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas WIX's P/E ratio is -74.50. In terms of profitability, GEN's ROE is +0.40%, compared to WIX's ROE of +0.19%. Regarding short-term risk, GEN is less volatile compared to WIX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check WIX's competition here
GEN vs CCC Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CCC has a market cap of 2.9B. Regarding current trading prices, GEN is priced at $26.61, while CCC trades at $4.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CCC's P/E ratio is 83.17. In terms of profitability, GEN's ROE is +0.40%, compared to CCC's ROE of +0.02%. Regarding short-term risk, GEN is less volatile compared to CCC. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CCC's competition here
GEN vs EEFT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, EEFT has a market cap of 2.7B. Regarding current trading prices, GEN is priced at $26.61, while EEFT trades at $66.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas EEFT's P/E ratio is 10.39. In terms of profitability, GEN's ROE is +0.40%, compared to EEFT's ROE of +0.24%. Regarding short-term risk, GEN is less volatile compared to EEFT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check EEFT's competition here
GEN vs STNE Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, STNE has a market cap of 2.6B. Regarding current trading prices, GEN is priced at $26.61, while STNE trades at $10.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas STNE's P/E ratio is 3.91. In terms of profitability, GEN's ROE is +0.40%, compared to STNE's ROE of +0.29%. Regarding short-term risk, GEN is less volatile compared to STNE. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check STNE's competition here
GEN vs PAGS Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, PAGS has a market cap of 2.5B. Regarding current trading prices, GEN is priced at $26.61, while PAGS trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas PAGS's P/E ratio is 6.08. In terms of profitability, GEN's ROE is +0.40%, compared to PAGS's ROE of +0.15%. Regarding short-term risk, GEN is less volatile compared to PAGS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PAGS's competition here
GEN vs BAND Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, BAND has a market cap of 2.3B. Regarding current trading prices, GEN is priced at $26.61, while BAND trades at $71.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas BAND's P/E ratio is -192.61. In terms of profitability, GEN's ROE is +0.40%, compared to BAND's ROE of -0.01%. Regarding short-term risk, GEN is less volatile compared to BAND. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check BAND's competition here
GEN vs AVPT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, AVPT has a market cap of 2.3B. Regarding current trading prices, GEN is priced at $26.61, while AVPT trades at $10.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas AVPT's P/E ratio is 54.45. In terms of profitability, GEN's ROE is +0.40%, compared to AVPT's ROE of +0.10%. Regarding short-term risk, GEN is less volatile compared to AVPT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check AVPT's competition here
GEN vs CSGS Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, CSGS has a market cap of 2.3B. Regarding current trading prices, GEN is priced at $26.61, while CSGS trades at $80.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas CSGS's P/E ratio is 36.02. In terms of profitability, GEN's ROE is +0.40%, compared to CSGS's ROE of +0.22%. Regarding short-term risk, GEN is more volatile compared to CSGS. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CSGS's competition here
GEN vs ATEN Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, ATEN has a market cap of 2.3B. Regarding current trading prices, GEN is priced at $26.61, while ATEN trades at $30.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas ATEN's P/E ratio is 52.00. In terms of profitability, GEN's ROE is +0.40%, compared to ATEN's ROE of +0.21%. Regarding short-term risk, GEN is less volatile compared to ATEN. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ATEN's competition here
GEN vs WRD Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, WRD has a market cap of 2.3B. Regarding current trading prices, GEN is priced at $26.61, while WRD trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas WRD's P/E ratio is -9.55. In terms of profitability, GEN's ROE is +0.40%, compared to WRD's ROE of -0.24%. Regarding short-term risk, GEN is less volatile compared to WRD. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check WRD's competition here
GEN vs RAMP Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, RAMP has a market cap of 2.2B. Regarding current trading prices, GEN is priced at $26.61, while RAMP trades at $37.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas RAMP's P/E ratio is 16.76. In terms of profitability, GEN's ROE is +0.40%, compared to RAMP's ROE of +0.15%. Regarding short-term risk, GEN is more volatile compared to RAMP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check RAMP's competition here
GEN vs AVDX Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, AVDX has a market cap of 2.1B. Regarding current trading prices, GEN is priced at $26.61, while AVDX trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas AVDX's P/E ratio is -250.00. In terms of profitability, GEN's ROE is +0.40%, compared to AVDX's ROE of -0.02%. Regarding short-term risk, GEN is more volatile compared to AVDX. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check AVDX's competition here
GEN vs GETVV Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, GEN is priced at $26.61, while GETVV trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas GETVV's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to GETVV's ROE of N/A. Regarding short-term risk, GEN is less volatile compared to GETVV. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check GETVV's competition here
GEN vs SPSC Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, SPSC has a market cap of 2.1B. Regarding current trading prices, GEN is priced at $26.61, while SPSC trades at $55.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas SPSC's P/E ratio is 23.28. In terms of profitability, GEN's ROE is +0.40%, compared to SPSC's ROE of +0.09%. Regarding short-term risk, GEN is less volatile compared to SPSC. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check SPSC's competition here
GEN vs FORG Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, FORG has a market cap of 2B. Regarding current trading prices, GEN is priced at $26.61, while FORG trades at $23.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas FORG's P/E ratio is -22.53. In terms of profitability, GEN's ROE is +0.40%, compared to FORG's ROE of -0.20%. Regarding short-term risk, GEN is less volatile compared to FORG. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check FORG's competition here
GEN vs GSKY Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, GEN is priced at $26.61, while GSKY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas GSKY's P/E ratio is 18.61. In terms of profitability, GEN's ROE is +0.40%, compared to GSKY's ROE of +5.47%. Regarding short-term risk, GEN is less volatile compared to GSKY. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check GSKY's competition here
GEN vs GET Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, GEN is priced at $26.61, while GET trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas GET's P/E ratio is 31.33. In terms of profitability, GEN's ROE is +0.40%, compared to GET's ROE of N/A. Regarding short-term risk, GEN is less volatile compared to GET. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check GET's competition here
GEN vs GENVR Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, GENVR has a market cap of 1.7B. Regarding current trading prices, GEN is priced at $26.61, while GENVR trades at $2.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas GENVR's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to GENVR's ROE of +0.40%. Regarding short-term risk, GEN is less volatile compared to GENVR. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check GENVR's competition here
GEN vs PAYO Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, PAYO has a market cap of 1.7B. Regarding current trading prices, GEN is priced at $26.61, while PAYO trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas PAYO's P/E ratio is 25.65. In terms of profitability, GEN's ROE is +0.40%, compared to PAYO's ROE of +0.10%. Regarding short-term risk, GEN is less volatile compared to PAYO. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PAYO's competition here
GEN vs MQ Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, MQ has a market cap of 1.7B. Regarding current trading prices, GEN is priced at $26.61, while MQ trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas MQ's P/E ratio is 403.00. In terms of profitability, GEN's ROE is +0.40%, compared to MQ's ROE of +0.00%. Regarding short-term risk, GEN is less volatile compared to MQ. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check MQ's competition here
GEN vs EVCM Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, EVCM has a market cap of 1.7B. Regarding current trading prices, GEN is priced at $26.61, while EVCM trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas EVCM's P/E ratio is 73.15. In terms of profitability, GEN's ROE is +0.40%, compared to EVCM's ROE of +0.04%. Regarding short-term risk, GEN is less volatile compared to EVCM. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check EVCM's competition here
GEN vs STER Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, GEN is priced at $26.61, while STER trades at $16.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas STER's P/E ratio is -98.47. In terms of profitability, GEN's ROE is +0.40%, compared to STER's ROE of -0.00%. Regarding short-term risk, GEN is more volatile compared to STER. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check STER's competition here
GEN vs ZUO Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, GEN is priced at $26.61, while ZUO trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas ZUO's P/E ratio is -19.65. In terms of profitability, GEN's ROE is +0.40%, compared to ZUO's ROE of -0.44%. Regarding short-term risk, GEN is more volatile compared to ZUO. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check ZUO's competition here
GEN vs SUMO Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, GEN is priced at $26.61, while SUMO trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas SUMO's P/E ratio is -11.36. In terms of profitability, GEN's ROE is +0.40%, compared to SUMO's ROE of -0.31%. Regarding short-term risk, GEN is more volatile compared to SUMO. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SUMO's competition here
GEN vs GB Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, GB has a market cap of 1.5B. Regarding current trading prices, GEN is priced at $26.61, while GB trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas GB's P/E ratio is 18.27. In terms of profitability, GEN's ROE is +0.40%, compared to GB's ROE of +0.35%. Regarding short-term risk, GEN is more volatile compared to GB. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check GB's competition here
GEN vs EVTC Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, EVTC has a market cap of 1.4B. Regarding current trading prices, GEN is priced at $26.61, while EVTC trades at $22.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas EVTC's P/E ratio is 10.93. In terms of profitability, GEN's ROE is +0.40%, compared to EVTC's ROE of +0.21%. Regarding short-term risk, GEN is less volatile compared to EVTC. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check EVTC's competition here
GEN vs RXT Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, RXT has a market cap of 1.4B. Regarding current trading prices, GEN is priced at $26.61, while RXT trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas RXT's P/E ratio is -9.16. In terms of profitability, GEN's ROE is +0.40%, compared to RXT's ROE of +0.12%. Regarding short-term risk, GEN is less volatile compared to RXT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check RXT's competition here
GEN vs BASE Comparison June 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 16B. In comparison, BASE has a market cap of 1.4B. Regarding current trading prices, GEN is priced at $26.61, while BASE trades at $24.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 16.89, whereas BASE's P/E ratio is -17.38. In terms of profitability, GEN's ROE is +0.40%, compared to BASE's ROE of -0.45%. Regarding short-term risk, GEN is more volatile compared to BASE. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check BASE's competition here